Hip fractures in users of first- vs. second-generation bisphosphonates

[1] Riggs BL(1995)The worldwide problem of osteoporosis insights afforded by epidemiology Bone 17(Suppl) 505S-511S

[2] Melton LJ(2000)Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721-739

[3] Klotzbuecher CM(2002)Fractures between the ages of 20 and 50 years increase women’s risk of subsequent fractures Arch Intern Med 162 33-36

[4] Ross PD(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 285 785-795

[5] Landsman PB(1999)Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group Arch Intern Med 159 1215-1220

[6] Wu F(2002)Management of postmenopausal osteoporosis: position statement of The North American Menopause Society Menopause 9 84-101

[7] Mason B(1996)An assessment of the burden of illness due to osteoporosis in Canada J Soc Obstet Gynaecol Can 18(Suppl) 15-24

[8] Horne A(1998)Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077-2082

[9] Kado DM(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541

[10] Browner WS(2001)Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333-340

[1] Riggs BL(1995)The worldwide problem of osteoporosis insights afforded by epidemiology Bone 17(Suppl) 505S-511S

[2] Melton LJ(2000)Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721-739

[3] Klotzbuecher CM(2002)Fractures between the ages of 20 and 50 years increase women’s risk of subsequent fractures Arch Intern Med 162 33-36

[4] Ross PD(2001)Osteoporosis prevention, diagnosis, and therapy JAMA 285 785-795

[5] Landsman PB(1999)Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group Arch Intern Med 159 1215-1220

[6] Wu F(2002)Management of postmenopausal osteoporosis: position statement of The North American Menopause Society Menopause 9 84-101

[7] Mason B(1996)An assessment of the burden of illness due to osteoporosis in Canada J Soc Obstet Gynaecol Can 18(Suppl) 15-24

[8] Horne A(1998)Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 2077-2082

[9] Kado DM(1996)Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535-1541

[10] Browner WS(2001)Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333-340